Recent News About Baxter View More

Illinois pharmaceutical manufacturing company settles charges of releasing wastewater into Long Lake

By Marian Johns | Nov 23, 2018

CHICAGO — An Illinois pharmaceutical manufacturing company will pay a $75,000 penality and help fund wetland restoration in the state for allegedly discharging wastewater into the Long Lake tributary.

FTC approves final order in Baxter-Claris $625 million acquisition

By Mark Iandolo | Sep 8, 2017

WASHINGTON (Legal Newsline) — The Federal Trade Commission (FTC) announced Aug. 30 that, following a public comment period, it has approved a final order against Baxter International Inc., resolving allegations that Baxter’s proposed $625 million acquisition of Claris Lifesciences’ injectable drugs business would be anti-competitive.

Investors allege Target made misleading statements

By Robbie Hargett | Jun 7, 2016

ST. PAUL, Minn. (Legal Newsline) - Investors are suing Target and two of its chief officers, alleging it misled investors over its Canadian operations.

The Record Network